Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. - Wikidata - awgldk - TriplyDB

Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.

Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.

http://www.wikidata.org/entity/Q36281844

about

Subcortical volumetric abnormalities in bipolar disorder A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer Brain Structural Effects of Psychopharmacological Treatment in Bipolar Disorder Cell atrophy and loss in depression: reversal by antidepressant treatment Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder Trehalose induced antidepressant-like effects and autophagy enhancement in mice Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation The effectiveness of anticonvulsants in psychiatric disorders Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.A Pilot Study for Discovering Candidate Genes of Chromosome 18q21 in Methamphetamine Abusers: Case-control Association Study.DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia.Posterior cerebellar vermal deficits in bipolar disorder.Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis.Lithium prevents aberrant NMDA-induced F-actin reorganization in neurons.Molecular pharmacology in a simple model system: implicating MAP kinase and phosphoinositide signalling in bipolar disorder.The inhibition kinetics of yeast glutathione reductase by some metal ions.Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway Preclinical Evidences for an Antimanic Effect of Carvedilol.Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder Progress in neuroprotective strategies for preventing epilepsy.Heritability and Familiality of Temperament and Character Dimensions in Korean Families with Schizophrenic Linkage Disequilibrium.Early intervention in bipolar disorder, part II: therapeutics Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex.Bipolar disorder: from genes to behavior pathways Target identification for CNS diseases by transcriptional profiling.Glucocorticoid receptors modulate mitochondrial function: A novel mechanism for neuroprotection Frequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature.Anti-depressant-like effect of peony: a mini-review.DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders.The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder.Staging and neuroprogression in bipolar disorder.Anaesthesia for positron emission tomography scanning of animal brains.Challenges in drug target discovery in bipolar disorder.Novel routes to bipolar disorder drug discovery.

P2860

Q23747500-E9F0E815-891C-47FE-9949-F2802FAA6E05 Q26741164-25A49C18-0704-4D5E-9120-384E8493C1A8 Q26777966-DA7B2F16-6DD5-4BAF-9D25-59CC99A1D776 Q26786245-E189C801-2413-4A7A-884D-F0A9C6F967E7 Q27013609-07E85195-7DC0-4040-BDCC-5DADB2C211B8 Q28251880-1355CFA1-96D4-4844-93E7-AAA37507520A Q28290140-776FDCB5-66A4-49EF-AE77-3A8D20C1FDAD Q28468536-A35A4273-E927-4BF6-8FE0-12F3DD8CF811 Q28572236-89A24B11-EF28-4204-9DBF-56A83F7B304C Q28744504-DB6A0DE2-21CA-4DD0-8776-8D9D3D400986 Q30488395-EBD62A4D-9BE4-4011-A958-7E42D4D3FBCB Q33618952-BDDD6F65-4D7D-4111-8EDE-3C4A2372E10D Q33727970-DA840DF5-6E68-406D-9796-386F50AADAFE Q33872654-3EEE667F-494B-48EB-9757-F1CE455E8289 Q33904292-36E7A3B9-A921-4D43-8507-00381072C004 Q34151554-5A77B596-098E-46A7-9364-F9E129F977AF Q34421875-6821DB3C-90BC-4D89-A7C6-EB2715A19F5A Q34548121-CA9B4C9D-9701-4A6B-A70B-962FF6E4BD77 Q34685818-084A19FF-2554-4A39-9E64-32AACFFDE34A Q35546227-B947E1C3-947D-491D-88CB-1A612E5C026D Q35657017-A2EAB491-265D-43CA-895C-175540AA6A74 Q35661134-C6C37977-1FBA-422A-97DC-ACE940E9755F Q35943834-33D33709-8CB8-4003-9D39-DFCB0B2F7AF3 Q36253556-424FCEAB-705F-4D8F-A679-4E7BEB704919 Q36480123-09DE3440-BD43-425D-8781-79D5260B4131 Q36739694-7111CF46-3A15-47C4-9CB0-EBDA497638EA Q36873015-C6D7B340-0298-47B8-B609-0321325F9862 Q37071007-6C45CD54-ADE5-4FA1-8A00-6FD6DF2EB885 Q37088689-367E1F06-6991-4CAB-9C7E-80A668D0A8BF Q37143399-738C859D-8179-4B77-A2EE-271E148A33CD Q37175279-FBCEC8B3-4285-4580-AF36-791449B4BE6C Q37324047-E5C38F25-9B45-48AA-84E4-FEA4D2FB2E75 Q37648736-5542A033-B400-4A48-B018-D3C428DBD78F Q37971138-DD31F69C-D01A-4DEF-967C-AB6992330D72 Q37998459-A3E70F4E-9491-4D6E-A474-2BE2BBAE256D Q38031289-E86D8110-F771-4B1A-A6F2-B44F5FF77DEF Q38054585-906B952F-B8D1-4B5E-90FB-A31E2F1DC945 Q38076701-1DC054C2-8673-431D-BBB6-867FD4ECDFE5 Q38082552-4D1DD333-899C-40BA-B0D4-84F12227AC35 Q38109244-3E708551-7918-4648-9B66-CC64224F4696

P2860

Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.

http://www.wikidata.org/entity/Q36281844

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Mood stabilizers target cellul ...... lopment of novel therapeutics.

@ast

Mood stabilizers target cellul ...... lopment of novel therapeutics.

@en

type

label

Mood stabilizers target cellul ...... lopment of novel therapeutics.

@ast

Mood stabilizers target cellul ...... lopment of novel therapeutics.

@en

prefLabel

Mood stabilizers target cellul ...... lopment of novel therapeutics.

@ast

Mood stabilizers target cellul ...... lopment of novel therapeutics.

@en

P1433

Q36281844-9A4842C5-2F6C-4CDC-AC2B-CD575A22648C

P1476

Q36281844-882D4789-1999-44C5-907B-CD54E071D9BC

P2093

Q36281844-401F8865-651B-4122-9309-21A88698CFDB

Q36281844-698CA643-B85B-479D-818E-D7D55CD3629C

Q36281844-95F107BB-95BC-4009-9DD3-A585F77ED1C1

Q36281844-C5A620FA-2390-427D-B959-C118329D6F4E

P2888

Q36281844-CEF091E9-B030-4204-B775-5824D515E0A0

P304

Q36281844-1D65F9C0-F592-4AA8-98D6-3D4FC698257F

P31

Q36281844-EC9CCF4B-C02A-44AD-A5AE-4A4B9BDEDC12

P356

Q36281844-D1A81C93-F381-4D70-BD05-DA3AA6E187AF

P433

Q36281844-25014C34-6375-42BA-9A76-8EDC4C1C62DD

P478

Q36281844-208C41EC-C8C8-4C37-BE39-CAC55A0BB301

P577

Q36281844-59581FC8-B1DB-4EC6-BE46-F3ED7B149777

P5875

Q36281844-649CF402-5FBB-4A5A-A843-B9F185081522

P6179

Q36281844-A7E41ED1-D751-493F-B3D9-BADBBA5E74F5

P698

Q36281844-A71BA68E-E365-418B-BD03-68A1A76D6F6F

P356

P1433

Molecular Neurobiology

P1476

Mood stabilizers target cellul ...... lopment of novel therapeutics.

@en

P2093

Husseini K Manji

http://www.w3.org/2001/XMLSchema#string

Robert J Schloesser

http://www.w3.org/2001/XMLSchema#string

Rosilla F Bachmann

http://www.w3.org/2001/XMLSchema#string

Todd D Gould

http://www.w3.org/2001/XMLSchema#string

P2888

P304

173-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1385/MN:32:2:173

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7551158

http://www.w3.org/2001/XMLSchema#string

P6179

1016649818

http://www.w3.org/2001/XMLSchema#string

P698

16215281

http://www.w3.org/2001/XMLSchema#string